AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Geriatr Psychiatry 1:244-248, August 1993
© 1993 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aisen, P. S.
Right arrow Articles by Davis, K. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Aisen, P. S.
Right arrow Articles by Davis, K. L.

CLINICAL AND RESEARCH REPORT

Response to Combination Cholinergic/Noradrenergic Treatments in a Patient With Alzheimer's Disease

Paul S. Aisen, M.D., Linda M. Bierer, M.D., Michael Davidson, M.D., Theresa M. Ryan, B.S., Ranti Kaminsky, M.D., and Kenneth L. Davis, M.D.

Department of Psychiatry, Box 1230, Mt. Sinai Medical Center, 1 Gustave L. Levy PI., New York, NY 10029.

A patient with probable Alzheimer's disease participated in four studies involving cholinergic and combination cholinergic/noradrenergic treatment regimens. This patient demonstrated clinically significant improvement only with the combination of physostigmine and clonidine. The implications of these findings are discussed with regard to strategies for neurotransmitter augmentation therapy for Alzheimer's disease.






HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 1993 American Association for Geriatric Psychiatry